애완동물 진단 시장 예측(-2034년) : 제품 유형, 동물 유형, 기술, 용도, 최종사용자, 유통 채널 및 지역별 세계 분석

According to Stratistics MRC, the Global Pet Diagnostics Market is accounted for $13.0 billion in 2026 and is expected to reach $28.7 billion by 2034 growing at a CAGR of 10.4% during the forecast period. Pet diagnostics encompass a comprehensive range of testing solutions used to detect diseases, monitor health conditions, and guide treatment decisions for companion animals. These tools include clinical chemistry analyzers, hematology systems, immunoassay platforms, molecular diagnostic devices, and advanced imaging systems. The increasing humanization of pets, rising pet healthcare expenditure, and growing prevalence of chronic diseases in animals are driving demand for accurate and rapid diagnostic solutions across veterinary clinics, reference laboratories, and animal hospitals worldwide.

Market Dynamics:

Driver:

Rising pet ownership and humanization of pets

Growing numbers of pet owners worldwide are treating their animals as family members, leading to increased willingness to spend on advanced diagnostic services. This emotional bond translates into higher veterinary visits, more frequent preventive screenings, and acceptance of sophisticated testing protocols previously reserved for human medicine. Pet owners now demand the same level of diagnostic precision for their animals that they expect for themselves, including early disease detection and comprehensive health monitoring. The trend is particularly pronounced in urban areas where disposable incomes are higher and pet adoption rates continue climbing, creating sustained demand across all diagnostic product categories.

Restraint:

High cost of advanced diagnostic equipment

Significant capital investment required for instruments such as molecular diagnostic systems and imaging equipment limits adoption, particularly in smaller veterinary practices. These sophisticated devices, while offering superior accuracy and faster results, carry price tags that many independent clinics cannot justify given their patient volumes. Additional costs for maintenance, calibration, and operator training further strain budgets. The economic pressure has led to consolidation in the veterinary sector, with corporate-owned practices better positioned to absorb these expenses. This disparity creates a two-tier market where advanced diagnostics remain concentrated in urban specialty centers while rural practices rely on basic equipment or external reference laboratories.

Opportunity:

Expansion of point-of-care diagnostic solutions

Portable and benchtop analyzers capable of delivering rapid results during a single patient visit are transforming veterinary medicine. These compact systems eliminate the delay of sending samples to external laboratories, enabling immediate clinical decision-making and improving treatment outcomes. Innovations in microfluidics and miniaturized optics have made point-of-care testing feasible for chemistry, hematology, and even molecular applications. For pet owners, faster results reduce anxiety and multiple visits; for practitioners, it increases efficiency and revenue per appointment. As technology costs decrease and accuracy improves, point-of-care diagnostics are poised for significant penetration across all veterinary practice sizes.

Threat:

Shortage of trained veterinary professionals

Limited availability of skilled veterinarians and veterinary technicians capable of operating advanced diagnostic equipment constrains market growth, particularly in emerging economies. Even when clinics purchase sophisticated analyzers, lack of trained personnel to perform tests accurately and interpret results leads to underutilization of equipment. The global shortage of veterinary professionals is projected to worsen as pet populations grow and existing practitioners retire. Without adequate training infrastructure, the full potential of advanced diagnostics cannot be realized, potentially driving consolidation of testing services into centralized laboratories and reducing the installed base of instruments across individual practices.

Covid-19 Impact:

The pandemic initially disrupted pet diagnostics through clinic closures and reduced routine visits, but this was followed by a strong rebound driven by pandemic pet adoptions. Lockdowns led to unprecedented pet acquisition rates, expanding the long-term patient base. Supply chain challenges affected reagent and consumable availability, while telemedicine adoption created new workflows for diagnostic ordering and result communication. The crisis accelerated digital transformation in veterinary diagnostics, with cloud-based data management and remote result access becoming standard expectations. Overall, the pandemic strengthened the pet healthcare market as owners valued their companions' health during isolation, establishing durable growth momentum.

The Consumables segment is expected to be the largest during the forecast period

The Consumables segment is expected to account for the largest market share during the forecast period, driven by the recurring nature of reagents, test kits, and sample collection supplies. Each diagnostic test performed requires fresh consumables, creating predictable and continuous revenue streams that surpass the one-time purchase of durable instruments. Veterinary clinics performing hundreds to thousands of tests monthly generate ongoing demand for these supplies. Additionally, consumables are vendor-specific in many cases, locking facilities into long-term purchasing relationships after instrument acquisition. The growing volume of diagnostic testing, combined with expansion of test menus and higher throughput, ensures consumables maintain their dominant market position.

The Cats (Feline) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Cats (Feline) segment is predicted to witness the highest growth rate, reflecting rapidly increasing cat ownership globally and the unique diagnostic challenges felines present. Cats are particularly skilled at hiding illness symptoms, making routine diagnostic screening essential for early disease detection. The rising prevalence of chronic feline conditions, including chronic kidney disease, hyperthyroidism, and diabetes, drives repeat testing requirements. Veterinary medicine has also advanced understanding of feline-specific biomarkers and reference ranges, enabling more accurate diagnostics. As cat owners increasingly embrace preventive healthcare and younger generations prioritize feline companions, demand for specialized feline diagnostic solutions accelerates substantially.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high pet ownership rates, advanced veterinary infrastructure, and substantial healthcare spending on companion animals. The region benefits from strong reimbursement options through pet insurance, which has higher penetration than any other global market. Major diagnostic manufacturers are headquartered in North America, ensuring rapid access to new technologies and consumables. The prevalence of corporate-owned veterinary consolidators, which standardize diagnostic protocols across hundreds of clinics, creates efficient distribution channels. Combined with a culture of preventive pet healthcare and high disposable incomes, North America maintains its leadership position.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by rising pet ownership among expanding middle classes and increasing awareness of advanced veterinary diagnostics. Countries including China, India, and Southeast Asian nations are witnessing rapid urbanization and shifting attitudes toward pet care, with animals transitioning from working or stray roles to cherished family members. Government initiatives promoting animal health and disease surveillance, particularly for rabies control and zoonotic disease prevention, support diagnostic infrastructure development. International manufacturers are establishing local partnerships and distribution networks to serve this growing market. As veterinary education improves and specialty practices emerge, Asia Pacific becomes the fastest-growing region.

Key players in the market

Some of the key players in Pet Diagnostics Market include Petmate, MidWest Homes for Pets, Go Pet Club, Ware Pet Products, Prevue Pet Products, Merry Products, PawHut, Trixie Heimtierbedarf GmbH, North American Pet Products, PetPals Group Inc., Armarkat, Furhaven Pet Products, PetFusion LLC, The Refined Feline, Designer Pet Products, Bowsers Pet Products, Enchanted Home Pet, and Critter Couch Company.

Key Developments:

In March 2026, Petmate unveiled its 2026 innovation lineup at the Global Pet Expo, debuting the "Ultra Cannon" automatic fetch system, the "Quirky Kitty Ocean Cool" cooling line for immersive enrichment, and an expansion of its "Wild Eats" collagen treat line with new venison varieties.

In June 2025, DARRAN Furniture launched the "Central Bark" collection, a specialized line of pet beds designed for service animals in modern workplaces, influencing the professional-grade pet furniture standards for players like MidWest Homes for Pets.

In November 2025, Trixie officially partnered with 3P Logistics to manage its expanding UK market growth, aiming to streamline supply chain operations and increase the availability of its lifestyle products in British retail outlets.

Products Covered:

• Instruments
• Consumables
• Services

Animal Types Covered:

• Dogs (Canine)
• Cats (Feline)
• Horses (Equine)
• Other Companion Animals

Technologies Covered:

• Clinical Biochemistry
• Immunodiagnostics
• Molecular Diagnostics
• Hematology
• Diagnostic Imaging
• Other Technologies

Applications Covered:

• Infectious Disease Testing
• Non-Infectious Disease Testing
• Genetic Testing
• Oncology Diagnostics
• Routine Health Screening

End Users Covered:

• Veterinary Hospitals & Clinics
• Diagnostic Laboratories
• Research Institutes
• Point-of-Care Settings

Distribution Channels Covered:

• Direct Sales
• Distributors & Wholesalers
• Online Channels

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Pet Diagnostics Market, By Product

• 5.1 Instruments
  • 5.1.1 Clinical Chemistry Analyzers
  • 5.1.2 Hematology Analyzers
  • 5.1.3 Immunoassay Analyzers
  • 5.1.4 Molecular Diagnostic Systems
  • 5.1.5 Imaging Systems
• 5.2 Consumables
  • 5.2.1 Reagents & Kits
  • 5.2.2 Test Panels & Strips
  • 5.2.3 Sample Collection Consumables
• 5.3 Services
  • 5.3.1 Reference Laboratory Services
  • 5.3.2 Diagnostic Software & Data Management

6 Global Pet Diagnostics Market, By Animal Type

• 6.1 Dogs (Canine)
• 6.2 Cats (Feline)
• 6.3 Horses (Equine)
• 6.4 Other Companion Animals

7 Global Pet Diagnostics Market, By Technology

• 7.1 Clinical Biochemistry
• 7.2 Immunodiagnostics
• 7.3 Molecular Diagnostics
• 7.4 Hematology
• 7.5 Diagnostic Imaging
• 7.6 Other Technologies

8 Global Pet Diagnostics Market, By Application

• 8.1 Infectious Disease Testing
• 8.2 Non-Infectious Disease Testing
• 8.3 Genetic Testing
• 8.4 Oncology Diagnostics
• 8.5 Routine Health Screening

9 Global Pet Diagnostics Market, By End User

• 9.1 Veterinary Hospitals & Clinics
• 9.2 Diagnostic Laboratories
• 9.3 Research Institutes
• 9.4 Point-of-Care Settings

10 Global Pet Diagnostics Market, By Distribution Channel

• 10.1 Direct Sales
• 10.2 Distributors & Wholesalers
• 10.3 Online Channels

11 Global Pet Diagnostics Market, By Geography

• 11.1 North America
  • 11.1.1 United States
  • 11.1.2 Canada
  • 11.1.3 Mexico
• 11.2 Europe
  • 11.2.1 United Kingdom
  • 11.2.2 Germany
  • 11.2.3 France
  • 11.2.4 Italy
  • 11.2.5 Spain
  • 11.2.6 Netherlands
  • 11.2.7 Belgium
  • 11.2.8 Sweden
  • 11.2.9 Switzerland
  • 11.2.10 Poland
  • 11.2.11 Rest of Europe
• 11.3 Asia Pacific
  • 11.3.1 China
  • 11.3.2 Japan
  • 11.3.3 India
  • 11.3.4 South Korea
  • 11.3.5 Australia
  • 11.3.6 Indonesia
  • 11.3.7 Thailand
  • 11.3.8 Malaysia
  • 11.3.9 Singapore
  • 11.3.10 Vietnam
  • 11.3.11 Rest of Asia Pacific
• 11.4 South America
  • 11.4.1 Brazil
  • 11.4.2 Argentina
  • 11.4.3 Colombia
  • 11.4.4 Chile
  • 11.4.5 Peru
  • 11.4.6 Rest of South America
• 11.5 Rest of the World (RoW)
  • 11.5.1 Middle East
    • 11.5.1.1 Saudi Arabia
    • 11.5.1.2 United Arab Emirates
    • 11.5.1.3 Qatar
    • 11.5.1.4 Israel
    • 11.5.1.5 Rest of Middle East
  • 11.5.2 Africa
    • 11.5.2.1 South Africa
    • 11.5.2.2 Egypt
    • 11.5.2.3 Morocco
    • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

• 12.1 Industry Value Network and Supply Chain Assessment
• 12.2 White-Space and Opportunity Mapping
• 12.3 Product Evolution and Market Life Cycle Analysis
• 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

• 13.1 Mergers and Acquisitions
• 13.2 Partnerships, Alliances, and Joint Ventures
• 13.3 New Product Launches and Certifications
• 13.4 Capacity Expansion and Investments
• 13.5 Other Strategic Initiatives

14 Company Profiles

• 14.1 IDEXX Laboratories Inc.
• 14.2 Zoetis Inc.
• 14.3 Thermo Fisher Scientific Inc.
• 14.4 Heska Corporation
• 14.5 Virbac
• 14.6 Neogen Corporation
• 14.7 BioNote Inc.
• 14.8 Randox Laboratories Ltd.
• 14.9 FUJIFILM Holdings Corporation
• 14.10 Abaxis Inc.
• 14.11 Mindray Medical International Limited
• 14.12 Eurofins Scientific
• 14.13 Agrolabo S.p.A.
• 14.14 Antech Diagnostics Inc.
• 14.15 Biochek BV
• 14.16 INDICAL Bioscience GmbH
• 14.17 VetScan
• 14.18 Bionote USA Inc.